ARCHIVES

NCI’s $65 Million to NTP Will Be Controversial, Untouchable; Spectre Of Another Backlog Looms

This article is from The Cancer Letter archive.

Vol. 06 No. 06 | February 8, 1980

Download PDF Visit The Full Archive

Related Articles

In Phase II Study, Vaccine IMA910 Stimulated Immune Response

February 24, 2012

Joseph Cullen, Cancer Prevention Leader, Dead At 54

November 30, 1990

NIH institute directors, in response to question from Sen. Arlen Specter, say Bush Administration’s stem cell research policy is harmful to NIH leadership in science.

April 8, 2005

In Brief: Cancer Control To Push Environmental Research Occupational Hazards; Bailer to Journal Post

May 24, 1974

Eight Win ASCO Young Investigator Awards

August 22, 1986

In Brief: Univ. of New Mexico Looked Over As Possible Comprehensive Center; Missouri Asks Delay

November 26, 1976